Abstract:High-throughput B-cell sequencing has opened up new avenues for investigating complex mechanisms underlying our adaptive immune response. These technological advances drive data generation and the need to mine and analyze the information contained in these large datasets, in particular the identification of therapeutic antibodies (Abs) or those associated with disease exposure and protection. Here, we describe our efforts to use artificial intelligence (AI)-based image-analyses for prospective classification of Abs based solely on sequence information. We hypothesized that Abs recognizing the same part of an antigen share a limited set of features at the binding interface, and that the binding site regions of these Abs share share common structure and physicochemical property patterns that can serve as a "fingerprint" to recognize uncharacterized Abs. We combined large-scale sequence-based protein-structure predictions to generate ensembles of 3-D Ab models, reduced the Ab binding interface to a 2-D image (fingerprint), used pre-trained convolutional neural networks to extract features, and trained deep neural networks (DNNs) to classify Abs. We evaluated this approach using Ab sequences derived from human HIV and Ebola viral infections to differentiate between two Abs, Abs belonging to specific B-cell family lineages, and Abs with different epitope preferences. In addition, we explored a different type of DNN method to detect one class of Abs from a larger pool of Abs. Testing on Ab sets that had been kept aside during model training, we achieved average prediction accuracies ranging from 71-96% depending on the complexity of the classification task. The high level of accuracies reached during these classification tests suggests that the DNN models were able to learn a series of structural patterns shared by Abs belonging to the same class. The developed methodology provides a means to apply AI-based image recognition techniques to analyze high-throughput B-cell sequencing datasets (repertoires) for Ab classification.

ABTrans: A Transformer-based Model for Predicting Interaction between Anti-Aβ Antibodies and Peptides

TransfIGN: A Structure-Based Deep Learning Method for Modeling the Interaction between HLA-A*02:01 and Antigen Peptides

Ab-Amy 2.0: Predicting light chain amyloidogenic risk of therapeutic antibodies based on antibody language model

AB-Amy: machine learning aided Amyloidogenic risk prediction of therapeutic antibody light chains

AbAgIntPre: A Deep Learning Method for Predicting Antibody-Antigen Interactions Based on Sequence Information

AttABseq: an Attention-Based Deep Learning Prediction Method for Antigen-Antibody Binding Affinity Changes Based on Protein Sequences.

Accurate prediction of antibody deamidations by combining high-throughput automated peptide mapping and protein language model-based deep learning

The Accurate Prediction of Antibody Deamidations by Combining High-Throughput Automated Peptide Mapping and Protein Language Model-Based Deep Learning

ProtTrans and Multi-Window Scanning Convolutional Neural Networks for the Prediction of Protein-Peptide Interaction Sites

AntiFormer: graph enhanced large language model for binding affinity prediction

Predicting drug-target binding affinity through molecule representation block based on multi-head attention and skip connection

Learning the Language of Antibody Hypervariability

Mechanism Exploration of Amyloid-β-42 Disaggregation by Single-Chain Variable Fragments of Alzheimer’s Disease Therapeutic Antibodies

Computational Analysis for the Rational Design of Anti-Amyloid Beta (ABeta) Antibodies

Computational Investigation of Gantenerumab and Crenezumab Recognition of Aβ Fibrils in Alzheimer's Disease Brain Tissue.

Developing machine-learning-based amyloid predictors with Cross-Beta DB

Protein language models enable prediction of polyreactivity of monospecific, bispecific, and heavy-chain-only antibodies

AbImmPred: An immunogenicity prediction method for therapeutic antibodies using AntiBERTy-based sequence features

AlphaBind, a Domain-Specific Model to Predict and Optimize Antibody-Antigen Binding Affinity

Using the antibody-antigen binding interface to train image-based deep neural networks for antibody-epitope classification

On Pre-trained Language Models for Antibody